IDT Supports the qPCR Community
News Jun 26, 2012
Integrated DNA Technologies (IDT) continues to provide support for life science applications with its latest successful webinar.
Over 1300 researchers registered for the live webinar entitled ‘State-of-the-art normalization of RT-qPCR data’, presented by Dr Jo Vandesompele, professor of functional genomics and applied bioinformatics at Ghent University and co-founder of real-time PCR company Biogazelle.
His expertise in the qPCR area includes numerous publications on normalization of gene expression and real-time PCR data analysis.
Available to view online, on-demand, the webinar addresses the potential pitfalls encountered when setting up a qPCR experiment. Without appropriate controls and data normalization, results can become inaccurate and misleading.
Dr Vandesompele therefore looked at the validation and selection of suitable reference genes, as well as the use of the global mean normalization method to obtain accurate data.
As a result, users can be confident in the reliability and repeatability of their amplifications. As a co-author of the MIQE guidelines, attendees benefited from Dr Vandesompele’s expertise and he was happy to answer any questions at the end of the talk.
Reinforcing the messaging of this webinar, IDT has released a free-to-download qPCR Application Guide, which provides valuable information on experimental overview, protocols, and troubleshooting.
With a dedication to developing innovative new products across qPCR, synthetic biology, RNAi, and next generation sequencing (to name a few), IDT is committed to providing useful and informative resources.
Stephen Gunstream, Vice President of Marketing at IDT commented, “Our continual investment into customer support and service, such as the development of our quarterly newsletter DECODED and the qPCR Applications Guide, has enabled us to really engage with our customers in a meaningful way - and this success has definitely been reflected in the number of registrants to this webinar. As a renowned expert within the field of qPCR, we were delighted to have Dr Vandesompele contribute not only to the recently updated qPCR Application Guide, but also in the presentation of this webinar.”
First Successful Gene Therapy Trial Reported for People with Hemophilia ANews
Patients with hemophilia A who received a single infusion of an investigational gene therapy showed improved levels of the essential blood clotting protein FVIII, with 11 of 13 achieving normal or near-normal FVIII levels.READ MORE
Cancer Gene Plays Key Role in Cystic Fibrosis Lung InfectionsNews
Recent findings explain why people with cystic fibrosis are particularly prone to respiratory infections—and suggest a new approach to treatment.READ MORE
Exploring African Genetic Diversity Unlocks Disease Susceptibility TraitsNews
African populations harbour the greatest genetic diversity and have the highest per capita health burden, yet they are rarely included in large genome studies of disease association, the authors of this study want to change this fact.READ MORE